Hingtgen SD - Search Results

1

Use of FLOSEAL® as a scaffold and its impact on induced neural stem cell phenotype, persistence, and efficacy.

Bomba HN, Carey-Ewend A, Sheets KT, Valdivia A, Goetz M, Findlay IA, Mercer-Smith A, Kass LE, Khagi S, Hingtgen SD. Bomba HN, et al. Among authors: hingtgen sd. Bioeng Transl Med. 2022 Jan 21;7(2):e10283. doi: 10.1002/btm2.10283. eCollection 2022 May. Bioeng Transl Med. 2022. PMID: 35600639 Free PMC article.

2

Neural stem cell therapy for cancer.

Bagó JR, Sheets KT, Hingtgen SD. Bagó JR, et al. Among authors: hingtgen sd. Methods. 2016 Apr 15;99:37-43. doi: 10.1016/j.ymeth.2015.08.013. Epub 2015 Aug 24. Methods. 2016. PMID: 26314280 Free PMC article. Review.

3

Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.

Bagó JR, Okolie O, Dumitru R, Ewend MG, Parker JS, Werff RV, Underhill TM, Schmid RS, Miller CR, Hingtgen SD. Bagó JR, et al. Among authors: hingtgen sd. Sci Transl Med. 2017 Feb 1;9(375):eaah6510. doi: 10.1126/scitranslmed.aah6510. Sci Transl Med. 2017. PMID: 28148846 Free PMC article.

4

Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.

Graham-Gurysh E, Moore KM, Satterlee AB, Sheets KT, Lin FC, Bachelder EM, Miller CR, Hingtgen SD, Ainslie KM. Graham-Gurysh E, et al. Among authors: hingtgen sd. Mol Pharm. 2018 Mar 5;15(3):1309-1318. doi: 10.1021/acs.molpharmaceut.7b01114. Epub 2018 Feb 2. Mol Pharm. 2018. PMID: 29342360 Free PMC article.

5

Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection.

Okolie O, Irvin DM, Bago JR, Sheets K, Satterlee A, Carey-Ewend AG, Lettry V, Dumitru R, Elton S, Ewend MG, Miller CR, Hingtgen SD. Okolie O, et al. Among authors: hingtgen sd. PLoS One. 2018 Jul 10;13(7):e0198596. doi: 10.1371/journal.pone.0198596. eCollection 2018. PLoS One. 2018. PMID: 29990322 Free PMC article.

6

Delivery of Cytotoxic Mesenchymal Stem Cells with Biodegradable Scaffolds for Treatment of Postoperative Brain Cancer.

Sheets KT, Bagó JR, Hingtgen SD. Sheets KT, et al. Among authors: hingtgen sd. Methods Mol Biol. 2018;1831:49-58. doi: 10.1007/978-1-4939-8661-3_5. Methods Mol Biol. 2018. PMID: 30051424

7

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds.

Sheets KT, Bagó JR, Paulk IL, Hingtgen SD. Sheets KT, et al. Among authors: hingtgen sd. J Vis Exp. 2018 Jul 16;(137):57452. doi: 10.3791/57452. J Vis Exp. 2018. PMID: 30059037 Free PMC article.

8

Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma.

Satterlee AB, Dunn DE, Lo DC, Khagi S, Hingtgen S. Satterlee AB, et al. Neuro Oncol. 2019 Dec 17;21(12):1552-1564. doi: 10.1093/neuonc/noz138. Neuro Oncol. 2019. PMID: 31420675 Free PMC article.

9

Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma.

Sheets KT, Ewend MG, Mohiti-Asli M, Tuin SA, Loboa EG, Aboody KS, Hingtgen SD. Sheets KT, et al. Among authors: hingtgen sd. Mol Ther. 2020 Apr 8;28(4):1056-1067. doi: 10.1016/j.ymthe.2020.02.008. Epub 2020 Feb 13. Mol Ther. 2020. PMID: 32109370 Free PMC article.

10

Impact of composite scaffold degradation rate on neural stem cell persistence in the glioblastoma surgical resection cavity.

Moore KM, Graham-Gurysh EG, Bomba HN, Murthy AB, Bachelder EM, Hingtgen SD, Ainslie KM. Moore KM, et al. Among authors: hingtgen sd. Mater Sci Eng C Mater Biol Appl. 2020 Jun;111:110846. doi: 10.1016/j.msec.2020.110846. Epub 2020 Mar 13. Mater Sci Eng C Mater Biol Appl. 2020. PMID: 32279815 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters